ArticleBlood cancer journal2023

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.

Maja Ludvigsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.